Quantcast

Fosamax suit can’t proceed based on ‘sham’ issue (access required)

Posted: 5:40 pm Thu, February 7, 2013
By Dolan Media Newswires

Irreconcilable contradictions in expert testimony prevented a product liability plaintiff from establishing that Merck failed to provide adequate warnings with the osteoporosis drug Fosamax, the 2nd Circuit has ruled in affirming judgment.

Subscribers get free access to our whitepaper library. Recent topics include:

  • The road less travelled: unusual legal practice areas
  • Exit strategy: a solo and small firm lawyer's guide to the how and when of retirement

Try us for 30 days and see!

Already a subscriber? Claim your Whitepapers here.

Comments

Comments are closed.






Minnesota Lawyer e-Brief

Legal news updates every Tuesday and Friday.
Email:

Follow us on social media



Privacy Policy • Subscriber Agreement • Contact Us • Subscribe • Advertise • About • The Dolan Company • Dolan Law Books • Dolan Business Books
Dolan Media Copyright © 2013 MINNESOTA LAWYERS  |   Minnesota Lawyer, 730 South Second Avenue, Minneapolis, MN 55402 (612)333-4244